Treating cancer via immunotherapy inducing vaccine going to human clinical trials soon

05/25/2015 - 00:00

A novel way of treating cancer using immunotherapy has been discovered in a joint research venture between Victoria University and the Malaghan Institute of Medical Research, and is on track to being tested on cancer patients.

The director of Victoria's Ferrier Research Institute, Professor Richard Furneaux, says the technology has been patented after successful laboratory trials, and a company called Avalia Immunotherapies has been established to further develop the ground-breaking treatment and progress it to clinical trials.

The discovery, which has been led by Ferrier's Dr Gavin Painter and Dr Ian Hermans from Malaghan, works as a therapeutic vaccine, activating the patient's own immune response to attack cancer cells in a patient's system.